As shown in Figs 3A, 3B, we found that, except for Loxl1 in the CGGA, all LOXs in GBM were more highly expressed in the mesenchymal subtypes than in the classical and proneural subtypes, indicating that LOXs could serve as diagnostic indicators for predicting mesenchymal subtypes in GBM patients. Here, LOXL1 is linked to glioblastoma.